* Trading in company's new shares on Euronext Amsterdam is expected to commence on Nov. 6
* Net proceeds from transaction to be used to support further clinical development of product Pq912 beyond ongoing phase 2A (Saphir) trial, support development of PBD-C06 and PQ1565 and exploration of other mechanism-related indications
Help employers find you! Check out all the jobs and post your resume.
* Net proceeds from transaction to be used to support further clinical development of product Pq912 beyond ongoing phase 2A (Saphir) trial, support development of PBD-C06 and PQ1565 and exploration of other mechanism-related indications
Help employers find you! Check out all the jobs and post your resume.
